Intercept Pharma Danmark ApS — Credit Rating and Financial Key Figures

CVR number: 37104469
Sundkrogsgade 21, 2100 København Ø

Income statement (kDKK)

2016
2017
2018
2019
Fiscal period length12121212
Net sales
Gross profit-9 118.00-9 178.001 001.002 803.87
Employee benefit expenses-14 538.00-16 695.00-8 086.00-2 397.85
EBIT-23 656.00-25 873.00-7 085.00406.01
Other financial income84.00
Other financial expenses0.14-63.00- 325.26
Pre-tax profit-23 656.00-25 789.00-7 148.0080.75
Income taxes- 107.98
Net earnings-23 656.00-25 789.00-7 148.00-27.22

Assets (kDKK)

2016
2017
2018
2019
Intangible assets total
Tangible assets total
Other receivables37.0037.0037.0043.96
Investments total37.0037.0037.0043.96
Long term receivables total
Inventories total
Current trade debtors479.00
Current amounts owed by group member comp.5 149.009 615.17
Prepayments and accrued income21.00
Current other receivables243.00442.0022.38
Short term receivables total722.005 612.009 637.55
Cash and bank deposits842.006 172.002 777.0039.06
Cash and cash equivalents842.006 172.002 777.0039.06
Balance sheet total (assets)879.006 931.008 426.009 720.56

Equity and liabilities (kDKK)

2016
2017
2018
2019
Share capital50.0050.0050.0050.00
Retained earnings-5 980.00-31 769.00-38 916.75
Profit of the financial year-23 656.00-25 789.00-7 148.00-27.22
Shareholders equity total-23 606.00-31 719.00-38 867.00-38 893.97
Non-current liabilities total
Current trade creditors1 568.00252.00305.0072.75
Current owed to group member21 385.0032 716.0046 286.0048 454.57
Short-term deferred tax liabilities65.91
Other non-interest bearing current liabilities1 532.005 414.00520.001.80
Accruals and deferred income268.00182.0019.51
Current liabilities total24 485.0038 650.0047 293.0048 614.53
Balance sheet total (liabilities)879.006 931.008 426.009 720.56
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.